Detailed information for compound 934683

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 500.9 | Formula: C25H20ClF3N4O2
  • H donors: 2 H acceptors: 3 LogP: 4.94 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C(C(C)C)NCc1ccc(c(c1)c1nc2nc(ccc2c(=O)[nH]1)c1ccc(cc1)C(F)(F)F)Cl
  • InChi: 1S/C25H20ClF3N4O2/c1-13(2)23(34)30-12-14-3-9-19(26)18(11-14)22-32-21-17(24(35)33-22)8-10-20(31-21)15-4-6-16(7-5-15)25(27,28)29/h3-11,13H,12H2,1-2H3,(H,30,34)(H,31,32,33,35)
  • InChiKey: VGZHNZPNCFKKSD-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens prostaglandin E synthase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum ko:K00799 glutathione S-transferase [EC2.5.1.18], putative Get druggable targets OG5_131112 All targets in OG5_131112
Schistosoma japonicum ko:K00799 glutathione S-transferase [EC2.5.1.18], putative Get druggable targets OG5_131112 All targets in OG5_131112
Schistosoma mansoni membrane associated proteins in eicosanoid and glutathione metabolism family member Get druggable targets OG5_131112 All targets in OG5_131112
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus alkaline phosphatase intestinal gene 2 0.2692 1 0.5
Treponema pallidum 5'-nucleotidase (ushA) 0.1708 0.5065 0.5
Toxoplasma gondii 5'-nucleotidase, C-terminal domain-containing protein 0.1708 0.5065 1
Schistosoma mansoni alkaline phosphatase 0.2692 1 1
Schistosoma mansoni alkaline phosphatase 0.2692 1 1
Echinococcus multilocularis intestinal type alkaline phosphatase 1 0.2692 1 0.5
Echinococcus granulosus alkaline phosphatase 0.2692 1 0.5
Echinococcus multilocularis alkaline phosphatase 0.2692 1 0.5
Echinococcus multilocularis intestinal type alkaline phosphatase 0.2692 1 0.5
Schistosoma mansoni 23-cyclic-nucleotide 2-phosphodiesterase 0.1708 0.5065 0.2391
Schistosoma mansoni 23-cyclic-nucleotide 2-phosphodiesterase 0.1703 0.504 0.2354
Echinococcus granulosus intestinal type alkaline phosphatase 1 0.2692 1 0.5
Giardia lamblia Hypothetical protein 0.0698 0 0.5
Echinococcus multilocularis alkaline phosphatase, intestinal, gene 2 0.2692 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 10 nM Inhibition of human recombinant mPGES-1 expressed in CHO cells using PGH2 as substrate incubated for 10 mins prior to substrate addition measured after 1 min ChEMBL. 25260492
IC50 (binding) = 11 nM Inhibition of mPGES-1 in human A549 cells assessed as inhibition of IL-1beta-induced PGE2 production incubated for 30 mins prior to IL-1beta challenge measured after 18 to 24 hrs ChEMBL. 25260492
IC50 (binding) = 328 nM Inhibition of mPGES-1 in human whole blood assessed as inhibition of LPS-induced PGE2 production after overnight incubation ChEMBL. 25260492

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.